Nuvalent
$102.78
16
-$1.96-1.88% Today
Statistics
Day High
105.06
Day Low
101.79
52W High
111.99
52W Low
66.29
Volume
69,226,482
Avg. Volume
-
Mkt Cap
7.52B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-1.340328
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-850.75MNet Income
Analyst Ratings
135.43Average Price Target
The highest estimate is 158.00.
From 14 ratings within the last 6 months. This is not an investment recommendation.
From 14 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NUVL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Array Technologies
ARRY
Mkt Cap1.1B
AMGEN
AMGN
Mkt Cap189.22B
TG Therapeutics
TGTX
Mkt Cap5.39B
Protagonist Therapeutics
PTGX
Mkt Cap6.31B
Incyte
INCY
Mkt Cap19.12B
Novartis
NVS
Mkt Cap297.35B
Pfizer
PFE
Mkt Cap153.13B
About
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase I/II clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Dr. James R. Porter Ph.D.
Employees
162
Country
United States
ISIN
US6707031075
Listings
0 Comments
Share your thoughts
FAQ
What is Nuvalent stock price today?▼
The current price of NUVL is $102.78 USD — it has decreased by -1.88% in the past 24 hours. Watch Nuvalent stock price performance more closely on the chart.
What is Nuvalent stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nuvalent stocks are traded under the ticker NUVL.
Is Nuvalent stock price growing?▼
NUVL stock has fallen by -1.82% compared to the previous week, the month change is a +3.18% rise, over the last year Nuvalent has showed a +46.76% increase.
What is Nuvalent market cap?▼
Today Nuvalent has the market capitalization of 7.52B
When is the next Nuvalent earnings date?▼
Nuvalent is going to release the next earnings report on May 07, 2026.
What were Nuvalent earnings last quarter?▼
NUVL earnings for the last quarter are -1.58 USD per share, whereas the estimation was -1.48 USD resulting in a -7.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nuvalent revenue for the last year?▼
Nuvalent revenue for the last year amounts to 0 USD.
What is Nuvalent net income for the last year?▼
NUVL net income for the last year is -850.75M USD.
How many employees does Nuvalent have?▼
As of April 16, 2026, the company has 162 employees.
In which sector is Nuvalent located?▼
Nuvalent operates in the Health & Wellness sector.
When did Nuvalent complete a stock split?▼
The last stock split for Nuvalent was on March 10, 2017 with a ratio of 1:1200000.
Where is Nuvalent headquartered?▼
Nuvalent is headquartered in Cambridge, United States.